EPA reaches $4.2M settlement over 2019 explosion and fire at a Philadelphia refinery

Date:

Share post:


PHILADELPHIA — The U.S. Environmental Protection Agency has reached a tentative $4.2 settlement with a firm that owned and operated a major East Coast refinery that was shuttered after an explosion and fire in 2019.

The deal with Philadelphia Energy Solutions was announced Tuesday. There will now be a 30-day public comment period before the settlement plan can be considered for final court approval. The company does not admit to any liability in the settlement, which the EPA said is the largest amount ever sought for a refinery under a Clean Air Act rule that requires owners and operators to ensure that regulated and other extremely hazardous substances are managed safely.

The EPA found that the company failed to identify and assess hazards posed by a pipe elbow in a hydrofluoric acid alkylation unit at the refinery in Philadelphia. The pipe elbow ruptured due to “extensive” corrosion that had withered the pipe wall to the thickness of a credit card since its installation in 1973.

The explosion and subsequent fire on June 21, 2019, eventually forced the refinery to close after being in operation for 150 years. At the time, it was the largest oil refining complex on the East Coast, processing 335,000 barrels of crude oil daily.

The EPA filed the claim in U.S. Bankruptcy Court in Delaware because the company entered bankruptcy shortly after the explosion. The 1,300-acre (526-hectare) site where the refinery had stood was sold in 2020 and is being redeveloped into industrial space and life sciences labs. It remains under a complex cleanup agreement under the oversight of the EPA and Pennsylvania Department of Environmental Protection.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Average rate on a 30-year mortgage in the US rises to highest level since July

The average rate on a 30-year mortgage in the U.S. edged closer to 7% this week as...

The biggest remaining unsanctioned Russian bank hit with U.S. sanctions, nearly three years into war

WASHINGTON -- Russia's third largest bank, Gazprombank and its six foreign subsidiaries were hit with U.S. sanctions...

Kenya cancels airport and energy deals with Adani group after the U.S. indicts the tycoon

NAIROBI, Kenya -- Kenya’s president said Thursday he has cancelled multimillion-dollar airport expansion and energy deals with...

North Korea and Russia agree to expand their economic cooperation

SEOUL, South Korea -- North Korea and Russia reached a new agreement for expanding economic cooperation following...

Stock market today: Asian shares mostly slip despite Nvidia's solid earnings report

TOKYO -- Asian shares were mostly lower on Thursday after a mixed close on Wall Street, with...

Feds outline 'necessary steps' for Colorado River agreement by 2026 but no recommendation yet

LAS VEGAS -- Federal water officials made public on Wednesday what they called “necessary steps” for seven...

A social media ban for children younger than 16 is introduced in Australia's Parliament

MELBOURNE, Australia -- Australia’s communications minister introduced a world-first law into Parliament on Thursday that would ban...

As US ramps up nuclear power, fuel supplier plans to enrich more uranium domestically

OAK RIDGE, Tenn. -- A supplier of fuel for nuclear power plants announced a $60 million expansion...